Role of thrombolytic agents in cardiac arrest

Emergency Medicine Journal

Volumn 23, Issue 10, 2006, Pages 747-752

  Pedley, D K ^a   Morrison, W G ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; PLACEBO; TENECTEPLASE;

BLEEDING; CIRCULATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; LUNG EMBOLISM; MORTALITY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; REVIEW; SAFETY; SAMPLE SIZE; SURVIVAL; THERAPY DELAY; ANIMAL; BRAIN CIRCULATION; DRUG EFFECT; METHODOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; CEREBROVASCULAR CIRCULATION; FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 34648879660     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2006.038067     Document Type: Review

References (42)

1. Bedell SE, Delbanco TL, Cook EF, et al. Survival after cardiopulmonary resuscitation in the hospital. N Engl J Med 1983;309:569-76.
2. Ballew KA, Philbrick JT, Caven DE, et al. Predictors of survival follow in hospital cardiopulmonary resuscitation: a moving target. Arch Intern Med 1994;154:2426-32.
3. Nichol G, Detsky AS, Stiell IG, et al. Effectiveness of emergency medical services for victims of out of hospital cardiac arrest: a metanalysis. Ann Emerg Med 1996;27:700-10.
4. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cordiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
5. Nolan JP, Morley PT, Vanden Hoek TL, et al. Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advanced Life Support Task Force of the International Liaison Committee on Resuscitation. Circulation 2003;108:118-21.
6. Nolan JP, De Latorre FJ, Steen PA, et al. Advanced life support drugs: do they work? Curr Opin Crit Care 2002; 8:212-18.
7. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Int Med 1991;229:331-5.
8. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivers of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629-33.
9. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
10. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999; 115:1695-707.
11. Sackett DL, Richardson WS, Rosenberg W. Evidence based medicine: how to practice and teach EBM. Edinburgh: Churchill Livingstone, 1998.
12. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
13. Böttiqer BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583-5.
14. Lederer W, Lichtenberger C, Pechlaner C, et al. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71-6.
15. Abu-Laban RB, Christenson JM, Innes GD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522-8.
16. Janata K, Holzer M, Kurkciyan I. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation 2003;57:49-55.
17. Lederer W, Lichtenberger C, Pechlaner C, et al. Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation 2004;61:123-9.
18. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA Trial). Resuscitation 2004;61:309-13.
19. Schreiber W, Gabriel D, Sterz F, et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 2002;52:63-9.
20. Ruiz-Bailen M, Aguayo de Hoyos E, Diaz-Castellanos MA. Role of thrombolysis in cardiac arrest. Intensive Care Med 2001; 27:438-41.
21. Voipio V, Kuisma M, Alaspaa A, et al. Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest. Resuscitation 2001;49:251-8.
22. Kurkciyan I, Meron G, Sterz F, et al. Major bleeding complications after cardiopulmonary resuscitation: impact of trombolytic treatment. J Intern Med 2003;253:128-35.
23. Tenaglia AN, Coliff RM, Candela RJ, et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cordial 1991;68:1015-19.
24. Böttiger BW, Spöhr F. The risk of thrombolysis in association with cardiopulmonary resuscitation - no reason to withhold this causal and effective therapy. J Int Med 2003; 253:99-101.
25. Kosits L. Administration of tenecteplase after prolonged cardiopulmonary resuscitation in a 46-year-old man with ventricular Fibrillation. J Emerg Nurs 2003;29:507-10.
26. Renkes-Hegendörfer U, Herrmann K. Successful treatment of a case of fulminant massive pulmonary embolism with streptokinase. Anaesthesist 1974;23:500-1.
27. The TIMI Study Group. The Trombolysis in Myocardial Infarction Trial. N Engl J Med 1985;312:932-6.
28. Newmann DH, Greenwald I, Callaway CW. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 2000;35:472-80.
29. Gando S, Kameue T, Nanzaki S, et al. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 1997; 77:278-82.
30. Böttiger BW, Motsch J, Böhrer H, et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995;92:2572-8.
31. Cannon CP, Gibson CM, McCabe CH, et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation 1998;98:2805-14.
32. Fischer M, Hossmann KA. No-reflow after cardiac arrest. Intens Care Med 1995;21:132-41.
33. Fischer M, Böttiger BW, Popov-Cenic S, et al. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intens Care Med 1996;22:1214-23.
34. Kim YH, Park JH, Hong SH, et al. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 1999;284:647-50.
35. Kilic E, Hermann DM, Hossman KA. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery occlusion in mice. Neuroreport 1999; 10:107-11.
36. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med 2001;344:395-402.
37. Murkin JM, Newman SP, Stump DA, et al. Statement of consensus on the assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg 1995;59:1289-95.
38. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation; the Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
39. Scholz KH, Tebbe U, Herrmann C, et al. Frequency of complications of cardiopulmonary Resuscitation after thrombolysis during acute myocardial infarction. Am J Cordial 1992;69:724-8.
40. Schiele R, Rustige J, Burcyk U, et al. Thrombolysis after resuscitation in acute myocardial infarction. J Am Coll Cordial 1996;27(Suppl A):279A.
41. Stewart BF, Weaver WD, Parsons LS, et al. Reperfusion therapy after pre-hospital cardiac arrest and its influence on outcome after acute myocardial infarction. J Am Coll Cardiol 1996; 27(Suppl A):278A.
42. Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf2003;26:367-79.